BGI and Merck Plan to Collaborate in Next-Gen Sequencing | GenomeWeb

By Julia Karow

This article, originally published Sept. 15, has been updated with comments form Illumina's CEO and from a Merck spokesperson.

Chinese genome center BGI and Merck plan to work together in order to build on their respective expertise in genome sequencing and pharmaceutical development, the partners said last week.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.